Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity

  • 1Email author,
  • 1,
  • 1,
  • 1,
  • 1, 2,
  • 1,
  • 1,
  • 1,
  • 1, 2,
  • 3 and
  • 1, 2
Journal of Translational Medicine201816:275

https://doi.org/10.1186/s12967-018-1656-7

  • Received: 4 October 2018
  • Accepted: 4 October 2018
  • Published:

The original article was published in Journal of Translational Medicine 2018 16:237

Correction to: J Transl Med (2018) 16:237 https://doi.org/10.1186/s12967-018-1613-5

Following publication of the original article [1], the authors reported that all of the authors’ names were processed incorrectly so that their given and family names were interchanged. In this Correction the correct author names are shown. The original publication of this article has been corrected.

The correct names are: Sara Castiglia, Aloe Adamini, Deborah Rustichelli, Laura Castello, Katia Mareschi, Giuseppe Pinnetta, Marco Leone, Alessandra Mandese, Ivana Ferrero, Giulia Mesiano and Franca Fagioli.

Notes

Declarations

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
City of Health and Science Hospital of Turin, Pediatric Oncoematology, Regina Margherita Children’s Hospital, Piazza Polonia 94, 10126 Turin, Italy
(2)
Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy
(3)
Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy

Reference

  1. Castiglia S, Adamini A, Rustichelli D, Castello L, Mareschi K, Pinnetta G, Leone M, Mandese A, Ferrero I, Mesiano G, Fagioli F. Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity. J Transl Med. 2018;16:237. https://doi.org/10.1186/s12967-018-1613-5.View ArticleGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement